Antibody conjugates comprising toll-like receptor agonist
US10973826B2 · kind B2 · utility
4Cited by
42References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2016 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | Apr 13, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibody conjugates comprising toll-like receptor agonists and the use of such conjugates for the treatment of cancer. In some embodiments, the conjugates comprise anti-HER2 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.